323 related articles for article (PubMed ID: 19726883)
1. Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition.
McCoy EL; Iwanaga R; Jedlicka P; Abbey NS; Chodosh LA; Heichman KA; Welm AL; Ford HL
J Clin Invest; 2009 Sep; 119(9):2663-77. PubMed ID: 19726883
[TBL] [Abstract][Full Text] [Related]
2. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling.
Micalizzi DS; Christensen KL; Jedlicka P; Coletta RD; Barón AE; Harrell JC; Horwitz KB; Billheimer D; Heichman KA; Welm AL; Schiemann WP; Ford HL
J Clin Invest; 2009 Sep; 119(9):2678-90. PubMed ID: 19726885
[TBL] [Abstract][Full Text] [Related]
3. Defining a role for the homeoprotein Six1 in EMT and mammary tumorigenesis.
Radisky DC
J Clin Invest; 2009 Sep; 119(9):2528-31. PubMed ID: 19726879
[TBL] [Abstract][Full Text] [Related]
4. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
[TBL] [Abstract][Full Text] [Related]
5. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.
Micalizzi DS; Wang CA; Farabaugh SM; Schiemann WP; Ford HL
Cancer Res; 2010 Dec; 70(24):10371-80. PubMed ID: 21056993
[TBL] [Abstract][Full Text] [Related]
6. SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer.
Wang CA; Jedlicka P; Patrick AN; Micalizzi DS; Lemmer KC; Deitsch E; Casás-Selves M; Harrell JC; Ford HL
J Clin Invest; 2012 May; 122(5):1895-906. PubMed ID: 22466647
[TBL] [Abstract][Full Text] [Related]
7. Eya2 is required to mediate the pro-metastatic functions of Six1 via the induction of TGF-β signaling, epithelial-mesenchymal transition, and cancer stem cell properties.
Farabaugh SM; Micalizzi DS; Jedlicka P; Zhao R; Ford HL
Oncogene; 2012 Feb; 31(5):552-62. PubMed ID: 21706047
[TBL] [Abstract][Full Text] [Related]
8. The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells.
Taylor MA; Parvani JG; Schiemann WP
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):169-90. PubMed ID: 20467795
[TBL] [Abstract][Full Text] [Related]
9. Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes.
Xu H; Zhang Y; Altomare D; Peña MM; Wan F; Pirisi L; Creek KE
Carcinogenesis; 2014 Jun; 35(6):1379-88. PubMed ID: 24574515
[TBL] [Abstract][Full Text] [Related]
10. Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation.
Coletta RD; Christensen KL; Micalizzi DS; Jedlicka P; Varella-Garcia M; Ford HL
Cancer Res; 2008 Apr; 68(7):2204-13. PubMed ID: 18381426
[TBL] [Abstract][Full Text] [Related]
11. The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1.
Coletta RD; Christensen K; Reichenberger KJ; Lamb J; Micomonaco D; Huang L; Wolf DM; Müller-Tidow C; Golub TR; Kawakami K; Ford HL
Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6478-83. PubMed ID: 15123840
[TBL] [Abstract][Full Text] [Related]
12. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
Micalizzi DS; Farabaugh SM; Ford HL
J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):117-34. PubMed ID: 20490631
[TBL] [Abstract][Full Text] [Related]
13. Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer.
Ponzo MG; Lesurf R; Petkiewicz S; O'Malley FP; Pinnaduwage D; Andrulis IL; Bull SB; Chughtai N; Zuo D; Souleimanova M; Germain D; Omeroglu A; Cardiff RD; Hallett M; Park M
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12903-8. PubMed ID: 19617568
[TBL] [Abstract][Full Text] [Related]
14. Autocrine PDGFR signaling promotes mammary cancer metastasis.
Jechlinger M; Sommer A; Moriggl R; Seither P; Kraut N; Capodiecci P; Donovan M; Cordon-Cardo C; Beug H; Grünert S
J Clin Invest; 2006 Jun; 116(6):1561-70. PubMed ID: 16741576
[TBL] [Abstract][Full Text] [Related]
15. TGF-β regulates Sca-1 expression and plasticity of pre-neoplastic mammary epithelial stem cells.
Remšík J; Pícková M; Vacek O; Fedr R; Binó L; Hampl A; Souček K
Sci Rep; 2020 Jul; 10(1):11396. PubMed ID: 32647280
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the Six1 homeobox gene in normal mammary gland morphogenesis.
Coletta RD; McCoy EL; Burns V; Kawakami K; McManaman JL; Wysolmerski JJ; Ford HL
BMC Dev Biol; 2010 Jan; 10():4. PubMed ID: 20074369
[TBL] [Abstract][Full Text] [Related]
17. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.
Liu S; Dontu G; Mantle ID; Patel S; Ahn NS; Jackson KW; Suri P; Wicha MS
Cancer Res; 2006 Jun; 66(12):6063-71. PubMed ID: 16778178
[TBL] [Abstract][Full Text] [Related]
18. Six1 Promotes Epithelial-Mesenchymal Transition in Bronchial Epithelial Cells via the TGFβ1/Smad Signalling Pathway.
Wang W; Yang Z; Li M; Wang Z; Shan Y; Qu Z
Int Arch Allergy Immunol; 2021; 182(6):479-488. PubMed ID: 33631753
[TBL] [Abstract][Full Text] [Related]
19. Stem cells in mammary development and carcinogenesis: implications for prevention and treatment.
Dontu G; Liu S; Wicha MS
Stem Cell Rev; 2005; 1(3):207-13. PubMed ID: 17142857
[TBL] [Abstract][Full Text] [Related]
20. EMT programs promote basal mammary stem cell and tumor-initiating cell stemness by inducing primary ciliogenesis and Hedgehog signaling.
Guen VJ; Chavarria TE; Kröger C; Ye X; Weinberg RA; Lees JA
Proc Natl Acad Sci U S A; 2017 Dec; 114(49):E10532-E10539. PubMed ID: 29158396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
